glp-1 before after Body Image Distortion Weight Loss Common With Drugs: Experts GLP-1 and weight loss injections

According to the 10th edition of the International Diabetes Federation (IDF) Diabetes Atlas, the global prevalence of diabetes in adults aged 2079 years is estimated to be 537 million, and this is predicted to rise to 783 million by 2045

doi: 10.1016/S0140-6736(21)00213-0

Interest stems mainly from their metabolic and weight-management effects, but robust human clinical trial evidence supporting direct thyroid or autoimmune benefits is lacking

GLP-1 receptor agonist intolerance refers to a situation where side effects become severe enough that a patient cannot continue treatment comfortably

Your GLP-1 receptors have adapted to sustained activation

It has passed phase 1 and 2 clinical trials and is currently in phase 3 trials, with an expected launch in 2026 or 2027 if approved